THERAVANCE BIOPHARMA INC

CUSIP: 88339KAA0 Class: NOTE

PALISADE CAPITAL MANAGEMENT, LP's Holding History (CIK: 0001009006)

Note: Option positions (PUT/CALL) are excluded.

Q2 2022
Shares 308,000 Value ($000) $286 Avg Close — Range —
Q1 2022
Shares 1,308,000 Value ($000) $1,254 Avg Close — Range —
Q4 2021
Shares 1,308,000 Value ($000) $1,259 Avg Close — Range —
Q3 2021
Shares 1,157,000 Value ($000) $1,076 Avg Close — Range —
Q2 2021
Shares 157,000 Value ($000) $148 Avg Close — Range —
Q1 2021
Shares 100,000 Value ($000) $102 Avg Close — Range —